Koers Radiko Holdings Corp. Canadian Securities Exchange
Aandelen
JUJU
CA75034R1029
Farmaceutische producten
Omzet 2018 | 107K 145K 98,05K | Omzet 2019 | 5,18 mln. 7,05 mln. 4,77 mln. | Marktkapitalisatie | 6,17 mln. 8,4 mln. 5,67 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -4 mln. -5,45 mln. -3,68 mln. | Nettowinst (verlies) 2019 | -10 mln. -13,62 mln. -9,2 mln. | EV/omzet 2018 | 101 x |
Nettoschuld 2018 | 259K 352K 238K | Nettoschuld 2019 | 1,98 mln. 2,7 mln. 1,82 mln. | EV/omzet 2019 | 1,57 x |
K/w-verhouding 2018 |
-1,5
x | K/w-verhouding 2019 |
-0,53
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 96,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16-04-18 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-19 |
Scott Reeves
BRD | Director/Board Member | 55 | 01-02-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16-04-18 |
Scott Reeves
BRD | Director/Board Member | 55 | 01-02-17 |
Robert Yosaitis
BRD | Director/Board Member | - | 12-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,25% | 709 mld. | |
+30,77% | 595 mld. | |
-1,71% | 367 mld. | |
+20,21% | 334 mld. | |
+5,59% | 289 mld. | |
+14,77% | 239 mld. | |
+9,13% | 211 mld. | |
-3,97% | 203 mld. | |
+9,19% | 171 mld. |